ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

July 5, 2002

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

October 23, 1981

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977